Revisiting the cardiovascular risk of hydroxychloroquine in RA.
Where this comes from
- Record sourced from PubMed, PMID 32999492.
- Also identified by DOI 10.1038/s41584-020-00521-x and PMC identifier 7525224.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cardiac toxicity can be induced by hydroxychloroquine, especially when used in combination with azithromycin. Interest in hydroxychloroquine and azithromycin as potential therapies for COVID-19 has renewed concerns about the possible cardiovascular risk these drugs present to patients with rheumatoid arthritis.
Medical subject headings
- Antimalarials
- Arthritis, Rheumatoid
- Cardiovascular Diseases
- Hydroxychloroquine